Back to top
more

Dentsply Sirona (XRAY)

(Delayed Data from NSDQ)

$14.31 USD

14.31
3,247,778

+0.01 (0.07%)

Updated Aug 4, 2025 03:59 PM ET

Pre-Market: $14.34 +0.03 (0.21%) 9:16 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (59 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Can DENTSPLY Sirona (XRAY) Deliver a Beat in Q2 Earnings?

by Zacks Equity Research

DENTSPLY Sirona's (XRAY) results are likely to be boosted by surging dental & healthcare consumables space in the yet-to-be-reported second quarter.

    Zacks Equity Research

    Will Flowserve (FLS) Pull Off a Surprise in Q2 Earnings?

    by Zacks Equity Research

    We expect second-quarter results of Flowserve (FLS) to gain traction from its strong operation model, solid productivity and geographical diversity.

      Zacks Equity Research

      Why an Earnings Beat is Likely for Waters Corp. (WAT) in Q2

      by Zacks Equity Research

      Waters Corp.'s (WAT) dominant position in the biopharma end markets and thriving sales in emerging markets will likely help it gain traction in the second quarter.

        Zacks Equity Research

        DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

        by Zacks Equity Research

        On Jul 12, we issued an updated research report on NY-based DENTSPLY SIRONA Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.

          Zacks Equity Research

          DENTSPLY SIRONA Renews Canadian Distribution Agreement

          by Zacks Equity Research

          DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced the renewal of an existing distribution agreement with Henry Schein Canada, Inc.

            Zacks Equity Research

            DENTSPLY (XRAY) Renews Partnership with Pacific Dental

            by Zacks Equity Research

            DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.

              Zacks Equity Research

              DENTSPLY (XRAY) Earnings and Revenues Miss Estimates in Q1

              by Zacks Equity Research

              DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 49 cents in the first quarter of 2017, missing the Zacks Consensus Estimate by 2 cents.

                Zacks Equity Research

                DENTSPLY (XRAY) Q1 Earnings Miss Estimates, Sales Up Y/Y

                by Zacks Equity Research

                DENTSPLY reported adjusted earnings of 49 cents per share, which missed the Zacks Consensus Estimate by 2 cents.

                  Zacks Equity Research

                  Medical Product Q1 Earnings Due on May 9: XRAY, HSIC & More

                  by Zacks Equity Research

                  Medical product, an important part of the medical device subcategory within the broader Medical sector, looks promising at the moment.

                    Kevin Cook headshot

                    Bull of the Day: Align Technology (ALGN)

                    by Kevin Cook

                    Clearly, investors will continue to smile with this 25% grower in their portfolios

                      Zacks Equity Research

                      Can DENTSPLY (XRAY) Pull a Surprise this Earnings Season?

                      by Zacks Equity Research

                      DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report first-quarter 2017 results on May 5.

                        Zacks Equity Research

                        DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?

                        by Zacks Equity Research

                        On Mar 20, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.

                          Zacks Equity Research

                          DENTSPLY (XRAY) Up 3.9% Since Earnings Report: Can It Continue?

                          by Zacks Equity Research

                          DENTSPLY (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                            Zacks Equity Research

                            New Strong Sell Stocks for February 28th

                            by Zacks Equity Research

                            Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                              Zacks Equity Research

                              DENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues

                              by Zacks Equity Research

                              DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 67 cents in the fourth quarter of 2016, surpassing the Zacks Consensus Estimate by 2 cents.

                                Zacks Equity Research

                                DENTSPLY (XRAY) Q4 Earnings Top Estimates, Sales Up Y/Y

                                by Zacks Equity Research

                                DENTSPLY reported adjusted earnings of 67 cents per share, which beat the Zacks Consensus Estimate by 2 cents and was higher than earnings of 65 cents in the year-ago quarter.

                                  Zacks Equity Research

                                  DENTSPLY (XRAY) Q4 Earnings: Is Disappointment in Store?

                                  by Zacks Equity Research

                                  York, PA-based DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report fourth-quarter 2016 results on Feb 10.

                                    Zacks Equity Research

                                    MedTech Tailwinds at a Glance: Which Stocks to Buy?

                                    by Zacks Equity Research

                                    Positive demographic trends and new product innovation have been the vital force behind the continued uptrend of the sector???s performance.

                                      Zacks Equity Research

                                      5 MedTech Stocks Poised to Trump Earnings in Q4

                                      by Zacks Equity Research

                                      MedTech's steady earnings trend reflects a strong product cycle and continuing innovation.